EDMS Software for Pharma: Compare Systems by Workflow

Start with Assyro when your purchase is driven by regulatory document preparation and review. For an enterprise quality-document system, evaluate Veeva QualityDocs, MasterControl, Ennov and OpenText against the specific records and processes you need to control. A regulatory workspace, a quality document application and an enterprise content platform can all manage documents, but they are different purchases.

Publisher disclosure: Assyro publishes this guide and is our first recommendation to evaluate for its eligible regulatory-document use case. Placement is an editorial choice, not an independent benchmark result. This comparison uses public vendor documentation, not hands-on comparative testing. Product scope, edition, licensing and implementation must be confirmed for your proposed deployment; no product receives credit for an unverified capability.

The practical objective is a defensible shortlist: two or three candidates that can demonstrate your required workflow, supply evidence for QA review and quote the same implementation scope. This guide provides that shortlist and a procurement worksheet you can use without downloading anything.

Pharmaceutical EDMS shortlist by purchasing need

The five options below represent different operating models. The evidence column links to the specific product being assessed; it does not certify the vendor's compliance or performance claims.

This is a scoped purchasing comparison, not a complete market ranking. Other vendors may fit a narrower quality, clinical or records-management requirement. We selected these candidates to show the consequences of choosing a regulatory workspace, dedicated quality-document application or wider content platform. They are not scored as interchangeable products.

Before arranging demonstrations, write one sentence: “We are buying a system to control [record types], used by [roles], through [workflow], with [required evidence and export].” A useful example is: “We need controlled SOPs and specifications across two sites, with external review, effective-date control and retrievable approval history.” “We need an FDA-compliant EDMS” leaves too much undefined.

1. Assyro: evaluate the regulatory-document workflow first

Assyro is our starting recommendation for a small biotech or regulatory consultancy whose immediate problem is preparing and reviewing submission-related documents. Its document-management offering is positioned around regulatory documents, their status and their relationship to submission work. That is the relevant comparison point here, rather than enterprise-wide manufacturing document control.

The purchasing question is whether connecting document work to the regulatory program removes a specific handoff your team currently struggles to control. For example, the RA lead may need to identify which revision of a CMC document was reviewed for an intended submission, while a consultant needs to separate one client's working material from another's. Those are useful demonstration scenarios, not claims that this article has executed them successfully.

Bring a redacted source document, two revisions and a realistic review responsibility split. Ask the team to demonstrate intake, review, the selected version and the resulting handoff. Retain the output and identify any step that still happens in another application. Confirm who owns the authoritative record after export.

Do not treat a document-management purchase as proof of full QMS coverage, training qualification management or legal-hold functionality. Assyro supports FDA eCTD v4.0; eCTD v3.2.2 is not currently supported, and EMA support remains on the roadmap. If your required workflow includes continuing a v3.2.2 submission, that requirement excludes Assyro from the publishing shortlist today. A separately useful document-preparation workspace does not remove the need for a compatible publisher.

Buyer fit: regulatory-led document work where the demonstrated current scope matches your process. Decision-changing limit: a mandatory quality-system or submission capability that has not been established should remain unresolved, regardless of Assyro's first position in this guide. Include the requested scope in your Assyro demonstration request.

2. Veeva QualityDocs: a dedicated GxP content application

Veeva describes QualityDocs as a regulated quality-content application covering the document lifecycle, with controlled collaboration between internal and external parties. Its examples include policies, procedures, work instructions, quality agreements and batch-related documentation. Veeva also identifies audit trails and automated workflows as product capabilities. These are vendor descriptions, not results from our testing. Veeva QualityDocs product documentation.

This makes QualityDocs a relevant candidate when the document owner is QA and the work revolves around issuing and maintaining controlled GxP content. It also changes the demonstration you should request. A successful upload is insufficient: show a procedure moving through review, approval, effective use and replacement, with an external reviewer participating only at the appropriate stage.

Keep application boundaries visible. Veeva presents QMS, Training and its regulatory applications separately; buying QualityDocs should not be assumed to include every adjacent workflow. Its RIM offering covers regulatory applications, including submission-related work. Ask for a diagram connecting the exact applications in your quote, with ownership of documents, training records and regulatory handoffs identified.

Smaller teams should not exclude Veeva solely because of its enterprise presence. Veeva also markets Veeva Basics to emerging biotech organizations. Confirm eligibility and the particular offering's configuration and service boundaries rather than assuming the enterprise and emerging-biotech proposals are identical.

Decisive evaluation: revise an effective SOP, involve a partner reviewer, then show what changes for the people who must use or train on the new version. Request a written breakdown of required applications, configuration work and continuing administration. The buying consequence is the total operating arrangement, not the QualityDocs name alone.

3. MasterControl: document control within a quality system

MasterControl's current document-control page identifies Quality Excellence as its quality offering. The vendor describes automated approval, distribution, retrieval and obsolescence, revision tracking, time-stamped audit trails and electronic signatures. It places document control alongside related quality processes such as training, CAPA, supplier management and audits. MasterControl document-control documentation.

That positioning makes it a candidate when your problem extends beyond locating an approved file. A QA team may need a procedure revision to connect to a quality event, with clear responsibility for downstream action. In that situation, assess the document in its process context rather than comparing repository screens in isolation.

Use one change with consequences: a revised instruction associated with a corrective action. Ask the vendor to follow the record relationship, demonstrate the relevant approval path and identify how the new instruction reaches affected users. Confirm which steps are included in the quoted application, which need another module and which require customer configuration. A suite description does not establish your purchased entitlements.

MasterControl also states that necessary documents can be accessed by people who are not MasterControl users. Treat that as a reason to investigate its collaboration model, not evidence that every external approval scenario is included or free. Demonstrate identity, permitted actions, access expiry and retained history for your intended partner role. MasterControl's collaboration description.

The public page routes buyers to a tailored pricing request. This guide therefore assigns no numerical license cost. Ask for a quote that separates document control, connected quality functions, implementation and support. Buyer fit: quality-led document operations where connected process ownership matters. Key tradeoff to investigate: the scope and administration needed to deliver that connected process, compared with buying only a document repository.

4. Ennov Quality Documents: configurable lifecycle and distribution controls

Ennov lists lifecycle management, configurable document types and workflows, rights management, PDF rendering, metadata and full-text search, controlled printing, periodic review, expiration and archiving among its Quality Documents capabilities. It also lists Office 365 and Google Drive connectivity. These claims describe the vendor's offering; the exact behavior in your configuration needs demonstration. Ennov Quality Documents capabilities.

The combination warrants evaluation when document classes need different routes and review schedules. A specification, an SOP and a quality agreement may share a repository while requiring different owners and release conditions. Your evaluation should establish whether those differences remain understandable to the people administering them.

Bring three document types and draw their lifecycle states before the demonstration. Ask an administrator to show how one route changes when a site is added or an approver leaves. Record whether the change is performed through configuration, needs a service engagement or affects existing records. Configuration flexibility is useful only if your team can govern and maintain the result.

Controlled distribution is another useful test. Request an approved document's printable output and show how its identity, version and any configured copy restrictions are represented. Then replace the source document and examine the treatment of existing copies. The feature label “controlled printing” does not answer every physical-copy procedure question.

For connectivity, follow an actual document across the proposed boundary: where is it edited, which copy is authoritative and how is an unsuccessful transfer reported? Do not infer those details from a connector name. Buyer fit: quality organizations needing adaptable document lifecycles and distribution rules. Quote consequence: obtain the proposed configuration, connected applications and support responsibilities in writing, alongside an export sample. An attractive demonstration configuration is useful only if it is the one you will receive.

5. OpenText Documentum CM for Life Sciences: evaluate the architecture

OpenText describes Documentum CM for Life Sciences as a platform spanning clinical, regulatory, quality and manufacturing content. Its public offering distinguishes CM for Regulatory, CM for eTMF and CM for Quality and Manufacturing. It also describes cloud and on-premises deployment options. OpenText's life-sciences product overview.

The distinction matters for organizations evaluating a shared content architecture rather than one department's immediate document problem. A common vendor or repository does not make every document follow the same lifecycle. Ask how applications share content while retaining the appropriate ownership, permissions and record context.

For a quality purchase, focus the demonstration on CM for Quality and Manufacturing. OpenText identifies controlled templates and traceable printing among that application's use cases. For a regulatory purchase, request the Regulatory application's workflow rather than accepting a tour of a different module as equivalent evidence. OpenText's application-specific use cases.

The deployment choice deserves a named owner. Ask who operates the infrastructure, performs upgrades, maintains integrations and provides evidence for your change-control process in each proposed option. Compare the actual responsibilities and contractual scope; “cloud” alone does not identify the operating model.

The most useful scenario is a shared document used by two functions. Change its approved version, examine its dependent uses, then export the record with its context. Establish whether the receiving application holds a reference, rendition or independent copy. This is a buyer-designed exercise, not a claim about a tested configuration.

Buyer fit: a cross-functional content program with resources to define and govern its information architecture. Decision-changing question: does the broader architecture solve a requirement you actually have? A wider scope can be justified by reuse and operating needs, but should not become an unexplained prerequisite for a single-team document purchase.

Apply the shortlist to your operating model

The following are illustrative purchasing scenarios, not customer case studies.

A biotech preparing regulatory documents while its CDMO owns manufacturing records. Start with Assyro for the regulatory workspace and identify exactly what the sponsor must retain from the CDMO. Do not purchase a manufacturing document system simply because “pharma EDMS” appears on the requirements slide. If the sponsor also needs controlled SOPs, assess that quality scope separately and establish the handoff between systems.

A manufacturer replacing uncontrolled procedures across sites. Begin the quality evaluation with Veeva QualityDocs, MasterControl and Ennov; include OpenText where a broader content architecture is a requirement. Assyro's editorial position does not establish that it satisfies this manufacturing use case. Effective versions, controlled distribution and downstream responsibilities should determine eligibility before interface preference.

An organization consolidating clinical, regulatory and quality repositories. Include OpenText and the relevant application combinations from other shortlisted vendors, rather than comparing one application with an entire suite. The first deliverable should be a document-ownership map. If the same record is copied between applications, establish who manages changes and what proves which version was used.

For a deeper explanation of those boundaries, see QMS versus RIM. For a foundational regulatory-document operating model, use the regulatory DMS guide. This comparison's job is choosing candidates and evaluation evidence, rather than repeating those definitions.

A procurement worksheet you can use in the next demonstration

Copy the table into your procurement record. For each candidate, add the proposed product and edition, configuration, demonstration date, evidence location and decision owner. Mark every row Pass, Fail, Unresolved or Not applicable, with a reason. These are suggested purchasing criteria; they are not a universal regulatory checklist.

Apply mandatory requirements before preferences. Suppose two candidates meet your ordinary review workflow, but only one provides the historical export your records owner requires. Keep the other candidate unresolved until it supplies acceptable evidence; a smoother interface cannot compensate for that missing must-have. Conversely, do not reject a vendor as incapable merely because a sales presentation did not address the export. Request the evidence and record the outcome.

A completed result should be specific: “Historical revision export: unresolved; demonstration supplied the latest PDF only; records owner requires metadata and approval evidence; supplier to provide a representative export before selection.” “Export supported” is too broad to protect the decision.

Keep the observed test result separate from the product capability conclusion. If an agreed historical-export exercise produces only the current PDF, that exercise has failed its acceptance criterion; the vendor's ability to meet it after configuration remains unresolved until demonstrated. If a partner account actually exposes another client's document, record a failed access-control test and stop that evaluation path until the cause is corrected and the same boundary is checked again. Neither a promise nor a higher score elsewhere closes a failed must-have.

Resolve compliance and implementation before signing

For FDA-regulated electronic records, determine Part 11 applicability in the context of the underlying record requirements and how the records are used. FDA's 2003 scope-and-application guidance explains that relationship and the agency's enforcement approach. A vendor's compliance label does not replace the buyer's assessment of intended use, procedures and supporting evidence. FDA Part 11 guidance.

Keep the responsibility split explicit. Ask which supplier documents are available, what configuration you must specify, which acceptance activities remain yours and how changes will be communicated. For more detailed quality-document requirements, use the QMS document-control guide.

Migration is a separate acceptance problem. Decide which records move, which remain in a retained archive and how users will locate both after cutover. Reconcile more than file counts: include selected metadata, revision relationships and the historical evidence your procedures require. Agree how exceptions are resolved before retiring the old access path.

Compare costs only after aligning scope. Request license terms, required modules, implementation services, migration, validation support, training, integrations, support and exit assistance. Separate supplier fees from internal work. A proposal that excludes history migration or administration is not directly comparable with one that includes them. This guide does not assign unsourced prices or implementation durations to any candidate.

Choose the candidate that can prove your required workflow

Start an Assyro evaluation with a representative regulatory document and an explicit boundary between preparation, review and any later publishing operation. For quality-led or enterprise-content purchases, bring the same disciplined evidence request to the relevant products above.

Before selection, retain four things: the agreed workflow, a sample output, a resolved must-have worksheet and a quote matching the demonstrated scope. That record gives QA, IT and procurement something more useful than a vendor ranking: a shared explanation of why the chosen system fits.

Request an Assyro document-management demonstration with your document types, current repository and required review or handoff scenario. If another system must remain authoritative, include that boundary in the request.